NeuroQuant
Cortechs.aiProduct specifications |
Information source:
Vendor
Last updated: Jan. 21, 2021 |
General | |
---|---|
Product name | NeuroQuant |
Company | Cortechs.ai |
Subspeciality | Neuro |
Modality | MR |
Disease targeted | Neurodegenerative brain disorders |
Key-features | Brain region quantification (75 structures), brain change data, normative data comparisons, dynamic atlas, custom report options |
Suggested use | Before: flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand) |
Data characteristics | |
Population | Patients aged 3-100 with suspicion of atrophy, edema, or abnormal brain development |
Input | 3D T1 sagittal MR sequence |
Input format | DICOM |
Output | segmentation overlays, brain change overlay, quantitative report with structure volumes, structure change data, and normative comparisons |
Output format | DICOM |
Technology | |
Integration | Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | > 10 minutes |
Certification | |
CE
|
Certified,
Class IIa
, MDD
|
FDA
|
510(k) cleared, Class II |
Market presence | |
On market since | 08-2006 |
Distribution channels | Blackford, Nuance, Eureka Clinical AI, Olea Medical, GE Healthcare, GMP, Getz Healthcare, Philips Intellispace |
Countries present (clinical, non-research use) | 43 |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of installations, Number of analyses |
Evidence | |
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |